Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

被引：0
|
作者：
Uy, Geoffrey L.
Rettig, Michael P.
Fletcher, Theresa
Riedell, Peter A.
Stockerl-Goldstein, Keith E.
Ghobadi, Armin
Jacoby, Meagan
Cashen, Amanda F.
Romee, Rizwan
Pusic, Iskra
Abboud, Camille N.
Schroeder, Mark A.
Vij, Ravi
Westervelt, Peter
DiPersio, John F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
    Palmieri, Raffaele
    Buckley, Sarah A.
    Othus, Megan
    Halpern, Anna B.
    Percival, Mary-Elizabeth M.
    Scott, Bart L.
    Hendrie, Paul C.
    Becker, Pamela S.
    Oehler, Vivian G.
    Estey, Elihu H.
    Walter, Roland B.
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1728 - 1731
  • [32] Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies
    Rubnitz, JE
    Razzouk, BI
    Srivastava, DK
    Pui, CH
    Ribeiro, RC
    Santana, VM
    LEUKEMIA RESEARCH, 2004, 28 (04) : 349 - 352
  • [33] Combination of mitoxantrone, topotecan and cytarabine in patients with refractory or relapsed AML or CML in blast crisis.
    Hoechsmann, B
    Döhner, H
    Ganser, A
    Heil, G
    Einsele, H
    Raghavachar, A
    Hoelzer, D
    Bergmann, L
    BLOOD, 2000, 96 (11) : 325A - 325A
  • [34] Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)
    Chaibi, P
    Dombret, H
    Rousselot, P
    Gardin, C
    Glaisner, S
    Castaigne, S
    Degos, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 822 - 822
  • [35] Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia
    Becker, Pamela S.
    Kantarjian, Hagop M.
    Appelbaum, Frederick R.
    Petersdorf, Stephen H.
    Storer, Barry
    Pierce, Sherry
    Shan, Jianqin
    Hendrie, Paul C.
    Pagel, John M.
    Shustov, Andrei R.
    Stirewalt, Derek L.
    Faderl, Stephan
    Harrington, Elizabeth
    Estey, Elihu H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (02) : 182 - 189
  • [36] PHASE 1 TRIAL OF G-CSF, CLADRIBINE, CYTARABINE, AND DOSE-ESCALATED MITOXANTRONE (G-CLAM) IN ADULTS WITH NEWLY DIAGNOSED AML OR HIGH-RISK MDS
    Anwar, A.
    Halpern, A.
    Scott, B.
    Becker, P.
    Othus, M.
    Hendrie, P.
    Ranker, E.
    Perdue, A.
    Chen, T.
    Buckley, S.
    Orlowski, K.
    Powell, M.
    Appelbaum, F.
    Estey, E.
    Walter, R.
    HAEMATOLOGICA, 2015, 100 : 219 - 219
  • [37] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC
    Liu, Jing
    Jia, Jinsong
    Gong, Li-Zhong
    Lu, Shen-ye
    Zhu, Hong-Hu
    Huang, Xiao-Jun
    Jiang, Hao
    BLOOD, 2017, 130
  • [38] Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China
    Zhang, Xi
    Li, Yunlong
    Zhang, Yanqi
    Chen, Xinghua
    Zhang, Cheng
    Gao, Li
    Kong, Peiyan
    Liu, Yao
    Wen, Qin
    Zeng, Yunjing
    Wang, Qingyu
    Su, Yi
    Wang, Chunsen
    Wang, Sanbin
    Yuan, Zhong
    Gao, Lei
    LEUKEMIA RESEARCH, 2013, 37 (06) : 657 - 664
  • [39] PHASE I STUDY OF SELINEXOR, A SELECTIVE INHIBITOR OF NUCLEAR EXPORT, IN COMBINATION WITH FLUDARABINE AND CYTARABINE IN CHILDREN WITH RELAPSED OR REFRACTORY LEUKEMIA
    Alexander, Thomas
    Ribeiro, Raul
    Pounds, Stanley
    Lacayo, Norman
    Rubnitz, Jeffrey
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S10 - S10
  • [40] Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients
    Scappini, Barbara
    Gianfaldoni, Giacomo
    Caracciolo, Francesco
    Mannelli, Francesco
    Biagiotti, Caterina
    Romani, Claudio
    Pogliani, Enrico M.
    Simonetti, Federico
    Borin, Lorenza
    Fanci, Rosa
    Cutini, Ilaria
    Longo, Giovanni
    Susini, Maria Chiara
    Angelucci, Emanuele
    Bosi, Alberto
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (12) : 1047 - 1051
12345